Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between kit ligand and cytokines in primary primitive progenitor cells

Molecular Cancer Research

Volumn 1, Issue 3, 2003, Pages 176-185

  Strife, Annabel ^a   Wisniewski, David ^a   Liu, Chongyuan ^a   Lambek, Caryl L ^a   Darzynkiewicz, Zbigniew ^c   Silver, Richard T ^b,d   Clarkson, Bayard ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CD34 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PROTEIN TYROSINE KINASE; STEM CELL FACTOR;

ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STEM CELL;

ANTIGENS, CD13; ANTIGENS, CD15; ANTIGENS, CD34; ANTIGENS, CD36; CELL DIVISION; CELLS, CULTURED; CYTOKINES; DRUG SYNERGISM; ERYTHROPOIETIN; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MYELOID PROGENITOR CELLS; PROTEIN-TYROSINE KINASES; PYRIDONES; PYRIMIDINES; STEM CELL FACTOR;

EID: 0037228088     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Caspersson, T., Gahrton, G., Lindsten, J., and Zech, L. Identification of the Philadelphia chromosome on a number 22 by quinacrine mustard fluorescence analysis. Exp. Cell Res., 63: 238-240, 1970.
2. De Klein, A., Hagemeijer, A., Bartram, C. R., Houwen, R., Hoefsloot, L., Carbonell, F., Chan, L., Barnett, M., Greaves, M., Kleihauer, E., Heisterkamp, N., Groffen, J., and Grosveld, G. bcr rearrangement and translocations of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. Blood, 68: 1369-1375, 1968.
3. Fialkow, P. J., Jacobson, R. J., and Papayannopoulou, T. Chronic myelocytic leukemia: clonal origin in a stem cell common to granulocyte, erythrocyte, platelet and monocyte/macrophage. Am. J. Med., 63: 125-130, 1977.
4. Groffen, J., Stephenson, J. R., Heisterkamp, N., de Klein, A., Bartram, C. R., and Grosveld, G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell, 36: 93-99, 1984.
5. Heisterkamp, N., Stephenson, S. R., Groffen, J., Hansen, P. F., de Klein, A., Bartram, C. R., and Grosveld, G. Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature, 306: 239-242, 1983.
6. Konopka, J. B., Watanabe, S. M., and Witte, O. N. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell, 37: 1035-1042, 1984.
7. Konopka, J. B. and Witte, O. N. Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Mol. Cell. Biol., 5: 3116-3123, 1985.
8. Rowley, J. D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine, fluorescence and Giemsa staining. Nature, 243: 290-293, 1973.
9. Shtivelman, E., Lifshitz, B., Gale, R. P., and Canaani, E. Fused transcript of abl and bcr genes in chronic myeloid leukaemia. Nature, 315: 550-554, 1985.
10. Clarkson, B. and Strife, A. Discordant maturation in chronic myelogenous leukemia. In: A. B. Deisseroth and R. B. Arlinghaus (eds.), Chronic Myelogenous Leukemia - Molecular Approaches to Research and Therapy, pp. 3-90. New York: Marcel Dekker, Inc., 1991.
11. Strife, A., Lambek, C., Wisniewski, D., Arlin, Z., Thaler, H., and Clarkson, B. Proliferative potential of subpopulations of granulocyte-macrophage progenitor cells in normal subjects and chronic myelogenous leukemia patients. Blood, 62: 389-397, 1983.
12. Strife, A. and Clarkson, B. Biology of chronic myelogenous leukemia: Is discordant maturation the primary defect? Semin. Hematol., 25: 1-19, 1988.
13. Strife, A., Lambek, C., Wisniewski, D., Wachter, M., Gulati, S. C., and Clarkson, B. D. Discordant maturation as the primary biological defect in chronic myelogenous leukemia. Cancer Res., 48: 1035-1041, 1988.
14. Strife, A., Perez, A., Lambek, C., Wisniewski, D., Bruno, S., Darzynkiewicz, Z., and Clarkson, B. Characterization of lineage-negative blast subpopulations derived from normal and chronic myelogenous leukemia bone marrows and determination of their responsiveness to human c-kit ligand. Cancer Res., 53: 401-409, 1993.
15. Strife, A., Perez, A., Lambek, C., Wisniewski, D., Bruno, S., Darzynkiewicz, Z., and Clarkson, B. Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand. Leuk. Res., 17: 799-807, 1993.
16. Moore, M. A. S. In vitro culture studies in chronic granulocytic leukaemia. Clin. Haematol., 6: 97-112, 1977.
17. Miller, A. M., Gross, M. A., and Yunis, A. A. Alterations in the properties of the myeloid colony forming unit in chronic myelocytic leukemia. Blood, 52: 290a, 1978.
18. Goldman, J. M., Shiota, F., Th'ng K. H., and Orchard, K. H. Circulating granulocytic and erythroid progenitor cells in chronic granulocytic leukaemia. Br. J. Haematol., 46: 7-13, 1980.
19. Goto, T., Nishikori, M., Arlin, Z., Gee, T., Kempin, S., Burchenal, J., Strife, A., Wisniewski, D., Lambek, C., Little, C., Jhanwar, S., Chaganti, R., and Clarkson, B. Growth characteristics of leukemic and normal hematopoietic cells in Ph'+ chronic myelogenous leukemia and effects of intensive treatment. Blood, 59: 793-808, 1982.
20. Coulombel, L., Kalousek, D. K., Eaves, C. J., Gupta, C. M., and Eaves, A. C. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. N. Engl. J. Med., 308: 1493-1498, 1983.
21. Olofsson, T. and Nilsson, B. Defective recloning capacity of granulocyte-macrophage colony-forming cells in chronic myeloid leukaemia. Scand. J. Haematol., 36: 168-175, 1986.
22. Eaves, C. J. and Eaves, A. C. Cell culture studies in CML. Bailliere's Clin. Haematol., 1: 931-961, 1987.
23. Petzer, A. L., Eaves, C. J., Barnett, M. J., and Eaves, A. C. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia. Blood, 90: 64-69, 1997.
24. Asano, M. and Kawahara, I. Ultramicroscopic characteristics of bone marrow cells in human chronic myeloid leukemia. Med. J. Shinshu Univ. (Japan), 13: 109-126, 1968.
25. Vainchenker, W., Guichard, J., and Deschamps, J. F. Megakaryocyte cultures in the chronic phase and in the blast crisis of chronic myeloid leukaemia: studies on the differentiation of the megakaryocyte progenitors and on the maturation of megakaryocytes in vitro. Br. J. Haematol., 51: 131-146, 1982.
26. Buckle A-M., Mottram, R., Pierce, A., Lucas, G. S., Russell, N., Miyan, J. A., and Whetton, A. D. The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells. Mol. Med., 6: 892-902, 2000.
27. Ashman, L. K. Review. The biology of stem cell factor and its receptor C-kit. Int. J. Biochem. Cell Biol., 31: 1037-1051, 1999.
28. Moore, S., Haylock, D. N., Levesque, J. P., McDiarmid, L. A., Samuels, L. M., Bik To, L., Simmons, P. J., and Hughes, T. P. Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34+ cells. Blood, 92: 2461-2470, 1998.
29. Buchdunger, E., Zimmermann, J., Mett, H., Meyer, T., Müller M., Druker, B. J., and Lydon, N. B. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res., 56: 100-104, 1996.
30. Heinrich, M. C., Griffith, D. J., Druker, B. J., Wait, C. L., Ott, K. A., and Zigler, A. J. Inhibition of c-kit receptor tyrosine kinase activity by ST1571 a selective tyrosine kinase inhibitor. Blood, 96: 925-932, 2000.
31. Swendeman, S., Nagar, B., Wisniewski, D., Strife, A., Lambek, C., Liu, C., Vcach, D., Bommann, W., Kuriyan, J., and Clarkson, B. Crystal structures of the c-Abl tyrosine kinase domain in complex with STI-571 and a novel Bcr-Abl inhibitor, PD173955. From the October 29th-November 2nd, 2001 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications, Miami Beach, FL, Abstract 568, 2001.
32. Wisniewski, D., Lambek, C. L., Liu, C., Strife, A., Vcach, D. R., Nagar B, Young, M. A., Schindler, T., Bommann, W. G., Bertino, J. R., Kuriyan, J., and Clarkson, B. Characterization of potent inhibitors of the Bcr-Abl and the c-Kit receptor tyrosine kinases. Cancer Res., 62: 4244-4255, 2002.
33. Hamby, J. M., Connolly, C. J., Schroeder, M. C., Winters, R. T., Showalter, H. D., Pan, R. L., Major, T. C., Olsewski, B., Ryan, M. J., Dahring, T., Lu, G. H., Keiser, J., Amar Shen, C., Kraker, A. J., Slintak, V., Nelson, J. M., Fry, D. W., Bradford, L., Hallak, H., and Doherty, A. M. Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors. J. Med. Chem., 40: 2296-2303, 1997.
34. Wisniewski, D., Strife, A., Wojciechowicz, D., Lambek, C., and Clarkson, B. Rapid communication: a 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations. Leukemia, 8: 688-693, 1994.
35. Wisniewski, D., Strife, A., Berman, E., and Clarkson, B. c-kit ligand stimulates tyrosine phosphorylation of a similar pattern of phosphotyrosyl proteins in primary primitive normal hematopoietic progenitors that are constitutively phosphorylated in comparable primitive progenitors in chronic phase chronic myelogenous leukemia. Leukemia, 10: 229-237, 1996.
36. Wisniewski, D., Strife, A., and Clarkson, B. Rapid communication: c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells. Leukemia, 10: 1436-1442, 1996.
37. Wisniewski, D., Strife, A., Swendeman, S., Erdjument-Bromage, H., Geromanos, S., Kavanaugh, W. M., Tempst, P., and Clarkson, B. A novel SH2-containing phosphatidyl-inositol 3,4,5-triphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells. Blood, 93: 2707-2720, 1999.
38. Gishizky, M. L. and Witte, O. N. Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro. Science, 256: 836-839, 1992.
39. Metcalf, D. The cellular basis for enhancement interactions between stem cell factor and the colony stimulating factors. Stem Cells, 11 (Suppl. 2): 1-11, 1993.
40. Metcalf, D. Review article. Hematopoietic regulators: redundancy or subtlety? Blood, 82: 3515-3523, 1993.
41. Wetzler, M., Talpaz, M., Van Etten, R. A., Hirsh-Ginsberg, C., Beran, M., and Kurzrock, R. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J. Clin. Invest., 92: 1925-1939, 1993.
42. Muta, K., Krantz, S. B., Bondurant, M. C., and Dai C-H. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood, 86: 572-580, 1995.
43. Issaad, C. and Vainchenker, W. Growth of erythroid colonies in chronic myelogenous leukemia is independent of erythropoietin only in the presence of Steel factor. Blood, 84: 3447-3456, 1994.
44. Ghaffari, S. Wu, H., Gerlach, M., Han, Y., Lodish, H. F., and Daley, G. Q. BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in crythropoietin receptor-deficient progenitor cells. Proc. Natl. Acad. Sci., 96: 13186-13190, 1999.
45. Wognum, A. W., Krystal, G., Eaves, C. J., Eaves, A. C., and Lansdorp, P. M. Increased erythropoietin-receptor expression on CD34-positive bone marrow cells from patients with chronic myeloid leukemia. Blood, 79: 642-649, 1992.
46. Strife, A., Lambek, C., Perez, A. M., Darzynkiewicz, Z., Skierski, J., Gulati, S., Haley, J., ten Dijke, P., Iwata, K., and Clarkson, B. D. The effects of transforming growth factor β3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood. Cancer Res., 51: 4828-4836, 1991.
47. Li, X. and Darzynkiewicz, Z. Cleavage of poly(ADP-ribose) polymerase measured in situ in individual cells: relationship to DNA fragmentation and cell cycle position during apoptosis. Exp. Cell Res., 255: 125-132, 2000.
48. Darzynkiewicz, Z., Bedner, E., Li, X., Gorczyca, W., Melamed, M. R. Laser scanning cytometry. A new instrumentation with many applications. Exp. Cell Res., 249: 1-12, 1999.
49. Kabarowski, J. H. S. and Witte, O. N. Consequences of BCR-ABL expression within the hematopoietic stem cell in chronic myeloid leukemia. Stem Cells, 18: 399-408, 2000.